| CAS No 371935-74-9 |
Phenol,3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]-null |
Inquiry |
| CAS No 366789-02-8 |
2-Thiophenecarboxamide,5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-null |
Inquiry |
| CAS No 36953-37-4 |
2(1H)-Pyridinone,4-bromo-null |
Inquiry |
| CAS No 36357-38-7 |
1-(6-methylpyridin-3-yl)ethan-1-onenull |
Inquiry |
| CAS No 361442-04-8 |
Saxagliptinnull |
Inquiry |
| CAS No 341031-54-7 |
Sunitinib malatenull |
Inquiry |
| CAS No 3140-73-6 |
2-Chloro-4,6-dimethoxy-1,3,5-triazinenull |
Inquiry |
| CAS No 3167-50-8 |
2-Aminopyrimidine-5-carboxylic acidnull |
Inquiry |
| CAS No 29421-73-6 |
Thiophene,3,5-dibromo-2-methyl-null |
Inquiry |
| CAS No 285-69-8 |
3,4-Epoxytetrahydrofurannull |
Inquiry |
| CAS No 272-52-6 |
1h-Pyrazolo[4,3-B]pyridinenull |
Inquiry |
| CAS No 261953-36-0 |
1H-Indazole, 6-iodo-null |
Inquiry |
| CAS No 26664-09-5 |
5-Pyrimidinecarboxaldehyde,4-amino-2-methoxy-null |
Inquiry |
| CAS No 231277-92-2 |
Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinaminenull |
Inquiry |
| CAS No 21462-39-5 |
clindamycin hydrochloridenull |
Inquiry |
| CAS No 18740-39-1 |
Thieno[2,3-d]pyrimidine,2,4-dichloro-null |
Inquiry |
| CAS No 170449-18-0 |
4-Quinazolinamine,N-(3-chlorophenyl)-6,7-dimethoxy-, hydrochloride (1:1)null |
Inquiry |
| CAS No 186407-74-9 |
4-BROMO (1H)INDAZOLEnull |
Inquiry |
| CAS No 1687-51-0 |
2-Quinazolinaminenull |
Inquiry |
| CAS No 156454-43-2 |
5-BROMO-7-METHYL-1H-INDAZOLEnull |
Inquiry |
| CAS No 16865-11-5 |
1H-Benzimidazole,2,5,6-trichloro-null |
Inquiry |
| CAS No 154447-36-6 |
4H-1-Benzopyran-4-one,2-(4-morpholinyl)-8-phenyl-null |
Inquiry |
| CAS No 154229-19-3 |
Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-, (3b)-null |
Inquiry |
| CAS No 153436-54-5 |
4-Quinazolinamine,N-(3-bromophenyl)-6,7-dimethoxy-null |
Inquiry |
| CAS No 150322-73-9 |
Cyclopropyl 2-fluorobenzyl ketonenull |
Inquiry |
